Search

Kenneth T. Lam

Examiner (ID: 17611, Phone: (571)270-1862 , Office: P/2631 )

Most Active Art Unit
2631
Art Unit(s)
2611, 2631
Total Applications
1175
Issued Applications
946
Pending Applications
89
Abandoned Applications
150

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19196553 [patent_doc_number] => 11993782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Lentivirus packaging system, lentivirus produced by the same, cell transduced by the lentivirus, method for improving lentivirus production in a host cell, and method of using the cell for treating cancer [patent_app_type] => utility [patent_app_number] => 17/377830 [patent_app_country] => US [patent_app_date] => 2021-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 5589 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17377830 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/377830
Lentivirus packaging system, lentivirus produced by the same, cell transduced by the lentivirus, method for improving lentivirus production in a host cell, and method of using the cell for treating cancer Jul 15, 2021 Issued
Array ( [id] => 18139897 [patent_doc_number] => 20230013733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => MICROCARRIERS WITH SCAFFOLD STRUCTURE AND CONTINUOUS OUTER WALL FOR CULTURING CELLS [patent_app_type] => utility [patent_app_number] => 17/374157 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5745 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374157 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/374157
MICROCARRIERS WITH SCAFFOLD STRUCTURE AND CONTINUOUS OUTER WALL FOR CULTURING CELLS Jul 12, 2021 Abandoned
Array ( [id] => 18628478 [patent_doc_number] => 20230287343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO [patent_app_type] => utility [patent_app_number] => 18/015489 [patent_app_country] => US [patent_app_date] => 2021-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17533 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015489 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015489
METHOD FOR GENERATING A THREE-DIMENSIONAL NEUROMUSCULAR ORGANOID IN VITRO Jul 11, 2021 Pending
Array ( [id] => 19280035 [patent_doc_number] => 20240216508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS [patent_app_type] => utility [patent_app_number] => 18/011780 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 129503 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011780 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/011780
ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS Jun 24, 2021 Pending
Array ( [id] => 17314820 [patent_doc_number] => 20210403868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => DEVICE FOR CELL CULTURE AND CELL CULTURING METHOD [patent_app_type] => utility [patent_app_number] => 17/304687 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304687 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/304687
DEVICE FOR CELL CULTURE AND CELL CULTURING METHOD Jun 23, 2021 Abandoned
Array ( [id] => 18530218 [patent_doc_number] => 20230235288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => PERIPHERAL BLOOD DERIVED SMALL PLURIPOTENT CELLS [patent_app_type] => utility [patent_app_number] => 18/002151 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002151 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002151
PERIPHERAL BLOOD DERIVED SMALL PLURIPOTENT CELLS Jun 20, 2021 Pending
Array ( [id] => 19359367 [patent_doc_number] => 20240261401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => ENGINEERED IMMUNE CELLS, COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/928414 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928414 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/928414
ENGINEERED IMMUNE CELLS, COMPOSITIONS AND METHODS THEREOF May 25, 2021 Abandoned
Array ( [id] => 17314480 [patent_doc_number] => 20210403528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => Novel T-Cell Receptor and Ligand [patent_app_type] => utility [patent_app_number] => 17/326661 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21597 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/326661
Novel T-Cell Receptor and Ligand May 20, 2021 Abandoned
Array ( [id] => 17228888 [patent_doc_number] => 20210355444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => METHOD FOR PRODUCING ERYTHROID CELLS AND/OR ERYTHROCYTES [patent_app_type] => utility [patent_app_number] => 17/319871 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319871 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319871
METHOD FOR PRODUCING ERYTHROID CELLS AND/OR ERYTHROCYTES May 12, 2021 Abandoned
Array ( [id] => 18418529 [patent_doc_number] => 20230172987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/997731 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 208596 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -379 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997731
PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY May 3, 2021 Pending
Array ( [id] => 17183875 [patent_doc_number] => 20210330760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => METHODS AND MATERIALS FOR TREATING OSTEOARTHRITIS [patent_app_type] => utility [patent_app_number] => 17/236726 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236726 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/236726
METHODS AND MATERIALS FOR TREATING OSTEOARTHRITIS Apr 20, 2021 Abandoned
Array ( [id] => 18451925 [patent_doc_number] => 20230193204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 17/996033 [patent_app_country] => US [patent_app_date] => 2021-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -132 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996033 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996033
TREATMENT OF ERECTILE DYSFUNCTION BY FIBROBLAST ADMINISTRATION Apr 9, 2021 Pending
Array ( [id] => 17140175 [patent_doc_number] => 20210308186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => Treatment of Acute Respiratory Distress Syndrome by T Regulatory Cells [patent_app_type] => utility [patent_app_number] => 17/224909 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224909 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/224909
Treatment of Acute Respiratory Distress Syndrome by T Regulatory Cells Apr 6, 2021 Abandoned
Array ( [id] => 18376012 [patent_doc_number] => 20230151094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => CHIMERIC ANTIGEN RECEPTORS TARGETING CD33 [patent_app_type] => utility [patent_app_number] => 17/995085 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995085 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995085
CHIMERIC ANTIGEN RECEPTORS TARGETING CD33 Mar 30, 2021 Pending
Array ( [id] => 18754314 [patent_doc_number] => 20230357711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE [patent_app_type] => utility [patent_app_number] => 18/026474 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9912 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18026474 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/026474
CELL SUPPORT AND METHOD OF PRODUCING SAME, CELL CULTURE METHOD AND CELL STRUCTURE Mar 22, 2021 Pending
Array ( [id] => 18323305 [patent_doc_number] => 20230121433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => CHIMERIC STIMULATORY RECEPTORS AND METHODS OF USE IN T CELL ACTIVATION AND DIFFERENTIATION [patent_app_type] => utility [patent_app_number] => 17/906034 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 83263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906034 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/906034
CHIMERIC STIMULATORY RECEPTORS AND METHODS OF USE IN T CELL ACTIVATION AND DIFFERENTIATION Mar 10, 2021 Pending
Array ( [id] => 18312183 [patent_doc_number] => 20230116083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS [patent_app_type] => utility [patent_app_number] => 17/908857 [patent_app_country] => US [patent_app_date] => 2021-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10023 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908857 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908857
UP-SCALED PRODUCTION OF MICROGLIA-LIKE/-PRECURSOR CELLS AND MACROPHAGE CELLS USING MESH MACROCARRIERS Mar 9, 2021 Pending
Array ( [id] => 18420486 [patent_doc_number] => 20230174948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => METHOD OF GENERATING ENDOTHELIAL CELLS [patent_app_type] => utility [patent_app_number] => 17/905691 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905691
METHOD OF GENERATING ENDOTHELIAL CELLS Mar 4, 2021 Pending
Array ( [id] => 16930881 [patent_doc_number] => 20210196770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => PLATFORM ONCOLYTIC VECTOR FOR SYSTEMIC DELIVERY [patent_app_type] => utility [patent_app_number] => 17/192736 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/192736
PLATFORM ONCOLYTIC VECTOR FOR SYSTEMIC DELIVERY Mar 3, 2021 Pending
Array ( [id] => 18649755 [patent_doc_number] => 20230295575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => METHODS OF INCREASING MATURATION OF HEART, PANCREATIC BETA-CELLS, AND NEURONS [patent_app_type] => utility [patent_app_number] => 17/760378 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/760378
METHODS OF INCREASING MATURATION OF HEART, PANCREATIC BETA-CELLS, AND NEURONS Feb 8, 2021 Abandoned
Menu